Management of Overweight and Obesity in Patients With Inflammatory Bowel Disease

Overview

Journal Gastroenterol Hepatol (N Y)

Date 2025 Jan 31

PMID 39886003

Authors

Mark Shneyderman

Hannah Freid

David Kohler

Jellyana Peraza

Natasha Haskey

Erin Abbott

Asher Kornbluth

Maitreyi Raman

Stephanie Gold

Affiliations

Soon will be listed here.

Abstract

Increasing evidence has linked obesity to complications of inflammatory bowel disease (IBD); however, data are limited on the efficacy and impact of weight management strategies on the disease course. There are a strikingly limited number of interventional studies on weight management in patients with IBD, and the recent nutrition and IBD guidelines published in the United States do not mention weight management strategies. Overweight and obesity management in patients with IBD should follow a stepwise approach to assessment and treatment, including lifestyle modification, anti-obesity medications such as glucagon-like peptide-1 agonists, endobariatric procedures, and bariatric surgery (if deemed appropriate). This article reviews the management of overweight and obesity in patients with IBD, examines the efficacy of currently available interventions and their impact on the IBD course, and proposes a stepwise approach to the assessment and treatment of overweight or obesity for the IBD provider.

References

Ridaura V, Faith J, Rey F, Cheng J, Duncan A, Kau A . Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341(6150):1241214. PMC: 3829625. DOI: 10.1126/science.1241214. View

Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S . Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology. Cell Rep. 2019; 26(10):2704-2719.e6. PMC: 6528490. DOI: 10.1016/j.celrep.2019.02.019. View

Bang-Berthelsen C, Holm T, Pyke C, Simonsen L, Sokilde R, Pociot F . GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation. Inflamm Bowel Dis. 2016; 22(9):2078-97. DOI: 10.1097/MIB.0000000000000847. View

Mian A, Khan S . Systematic review: Outcomes of bariatric surgery in patients with inflammatory bowel disease and de-novo IBD development after bariatric surgery. Surgeon. 2022; 21(2):e71-e77. DOI: 10.1016/j.surge.2022.04.008. View

Yarur A, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B . Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. Gastroenterology. 2023; 165(4):963-975.e5. PMC: 10589067. DOI: 10.1053/j.gastro.2023.06.036. View

Thiennimitr P, Yasom S, Tunapong W, Chunchai T, Wanchai K, Pongchaidecha A . Lactobacillus paracasei HII01, xylooligosaccharides, and synbiotics reduce gut disturbance in obese rats. Nutrition. 2018; 54:40-47. DOI: 10.1016/j.nut.2018.03.005. View

Zhang Z, Mocanu V, Cai C, Dang J, Slater L, Deehan E . Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review. Nutrients. 2019; 11(10). PMC: 6835402. DOI: 10.3390/nu11102291. View

Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M . Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA. 2023; 330(18):1795-1797. PMC: 10557026. DOI: 10.1001/jama.2023.19574. View

Ng V, Millard W, Lebrun C, Howard J . Low-intensity exercise improves quality of life in patients with Crohn's disease. Clin J Sport Med. 2007; 17(5):384-8. DOI: 10.1097/JSM.0b013e31802b4fda. View

10.

Lee S, Lee S, Yang E, Kim E, Kim J, Shin D . Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance. PLoS One. 2015; 10(9):e0135858. PMC: 4567351. DOI: 10.1371/journal.pone.0135858. View

11.

Bischoff S, Bager P, Escher J, Forbes A, Hebuterne X, Lodberg Hvas C . ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clin Nutr. 2023; 42(3):352-379. DOI: 10.1016/j.clnu.2022.12.004. View

12.

Kahles F, Meyer C, Mollmann J, Diebold S, Findeisen H, Lebherz C . GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering. Diabetes. 2014; 63(10):3221-9. DOI: 10.2337/db14-0100. View

13.

Felipe L, Bachi A, Oliveira M, Moreira S, Afonso J, Lino M . Effects of Roux-en-Y gastric bypass on the metabolic profile and systemic inflammatory status of women with metabolic syndrome: randomized controlled clinical trial. Diabetol Metab Syndr. 2023; 15(1):19. PMC: 9930348. DOI: 10.1186/s13098-023-00986-2. View

14.

Gold S, Raman M, Sands B, Ungaro R, Sabino J . Review article: Putting some muscle into sarcopenia-the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2023; 57(11):1216-1230. DOI: 10.1111/apt.17498. View

15.

Wu J, Man D, Shi D, Wu W, Wang S, Wang K . Intermittent Fasting Alleviates Risk Markers in a Murine Model of Ulcerative Colitis by Modulating the Gut Microbiome and Metabolome. Nutrients. 2022; 14(24). PMC: 9788567. DOI: 10.3390/nu14245311. View

16.

Gold S, Kornbluth A . The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement. Am J Gastroenterol. 2024; . DOI: 10.14309/ajg.0000000000002791. View

17.

Bazerbachi F, Sawas T, Vargas E, Haffar S, Deepak P, Kisiel J . Bariatric Surgery Is Acceptably Safe in Obese Inflammatory Bowel Disease Patients: Analysis of the Nationwide Inpatient Sample. Obes Surg. 2017; 28(4):1007-1014. DOI: 10.1007/s11695-017-2955-4. View

18.

Bischoff S, Barazzoni R, Busetto L, Campmans-Kuijpers M, Cardinale V, Chermesh I . European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterol J. 2022; 10(7):663-720. PMC: 9486502. DOI: 10.1002/ueg2.12280. View

19.

Zhu L, Fu J, Xiao X, Wang F, Jin M, Fang W . Faecal microbiota transplantation-mediated jejunal microbiota changes halt high-fat diet-induced obesity in mice via retarding intestinal fat absorption. Microb Biotechnol. 2021; 15(1):337-352. PMC: 8719817. DOI: 10.1111/1751-7915.13951. View

20.

Lahtinen P, Juuti A, Luostarinen M, Niskanen L, Liukkonen T, Tillonen J . Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery: A Randomized Clinical Trial. JAMA Netw Open. 2022; 5(12):e2247226. PMC: 9856235. DOI: 10.1001/jamanetworkopen.2022.47226. View